PANEL DISCUSSION: Lessons Learned from Failed and Discontinued Clinical Trials for the Treatment of Glioblastoma

Time: 5:45 pm
day: Day Two


  • Debate the common challenges with moving GBM clinical trials forward
  • What can we learn from the plethora of failed phase 2 trials?
  • With a high failure rate of phase 3 glioblastoma trials, panellists examine the need for greater reliability of earlier studies